This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Freedman, S. B. Articles by Maseri, A. Search for Related Content PubMed PubMed Citation Articles by Freedman, S. B. Articles by Maseri, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ERGONOVINE

Circulation, Vol 70, 178-183, Copyright © 1984 by American Heart Association

ARTICLES

Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?

SB Freedman, S Chierchia, L Rodriguez-Plaza, R Bugiardini, G Smith and A Maseri

Because ergonovine appears to produce coronary contractions by a serotonergic (5-HT) mechanism, we attempted to prevent ergonovine- induced ischemia in patients with vasospastic angina by pretreatment with ketanserin, a new selective 5-HT blocker. We studied seven patients with consistently positive results of ergonovine testing (ST segment elevation in three and ST segment depression in four). Ergonovine testing was performed before and after a bolus of 10 mg of ketanserin (all patients) and infusion of 2 to 4 mg/hr for 8 hr (six patients). To assess 5-HT blockade during ketanserin infusion, the constrictor response of hand veins to 5-HT was tested before and after ketanserin. Despite evidence of 5-HT blockade in hand veins, ergonovine- induced ischemia was not prevented by ketanserin in any patient, and there was no significant change in the dose of ergonovine required to provoke ischemia. In one patient, four spontaneous episodes of ST segment elevation occurred during infusion of ketanserin. The plasma concentrations of ketanserin at the time of ergonovine testing ranged from 61 to 127 ng/ml (mean 102) and were well above those that completely inhibit canine coronary 5-HT contractions in vitro. Although human coronary arteries may differ in their responsiveness to 5-HT or ketanserin, these data suggest that ischemia from ergonovine-induced coronary vasospasm is not mediated by 5-HT receptors.

This article has been cited by other articles:

				S. Lopes, P. Calvinho, F. de Oliveira, and M. Antunes Allograft aortic root replacement in complex prosthetic endocarditis Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 126 - 130. [Abstract] [Full Text] [PDF]

				C. A. Mestres and J. M. Miro Editorial comment: Allograft aortic root replacement in complex prosthetic valve endocarditis Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 131 - 132. [Full Text] [PDF]

				J. F. Sabik, B. W. Lytle, E. H. Blackstone, A. G.M. Marullo, G. B. Pettersson, and D. M. Cosgrove Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis Ann. Thorac. Surg., September 1, 2002; 74(3): 650 - 659. [Abstract] [Full Text] [PDF]

				P. Palka, S. Harrocks, A. Lange, D. J. Burstow, and M. F. O'Brien Primary Aortic Valve Replacement With Cryopreserved Aortic Allograft: An Echocardiographic Follow-Up Study of 570 Patients Circulation, January 1, 2002; 105(1): 61 - 66. [Abstract] [Full Text] [PDF]

				T. Katsumata and S. Westaby Homograft Aortic Replacement for Infected Mediastinal False Aneurysm Ann. Thorac. Surg., November 1, 1997; 64(5): 1464 - 1466. [Abstract] [Full Text]

				S. Westaby, A. Parry, and R. Pillai Aortic root replacement: modifications of technique with improvements in technology Eur. J. Cardiothorac. Surg., January 1, 1992; 6(suppl_1): S44 - S49. [Abstract] [PDF]

				Y. Aizawa, S. Niwano, M. Aizawa, M. Tamura, and A. Shibata Attenuation of the Vasoconstrictor Action of Neuropeptide-Y by Calcium-Channel Blockers Angiology, October 1, 1989; 40(10): 890 - 894. [Abstract] [PDF]